WHO Recommends Injectable Lenacapavir for HIV Prevention

On 14th July 2025, the World Health Organization (WHO) released new guidelines recommending injectable lenacapavir (LEN) twice a year as a pre-exposure prophylaxis (PrEP) option for HIV prevention—marking a landmark policy shift unveiled at the International AIDS Society (IAS) 2025 conference in Kigali, Rwanda.

  • LEN is the first twice-yearly injectable PrEP, offering a long-acting, highly effective alternative to daily oral pills—particularly beneficial for individuals facing stigma, daily adherence issues, or limited healthcare access.
  • WHO’s recommendation comes as HIV prevention progress stalls, with 1.3 million new infections in 2024, disproportionately affecting sex workers, men who have sex with men, transgender people, people who ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Science & Technology